Elevated Plasma Chromogranin-A Concentrations in Prostatic Carcinoma
- 1 August 1991
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 146 (2 Part 1), 358-361
- https://doi.org/10.1016/s0022-5347(17)37793-5
Abstract
Chromogranin-A is considered a sensitive immunohistochemical tissue marker in neuroendocrine prostatic carcinoma. We report that the plasma chromogranin-A level was elevated in 48% of 25 patients with stage D2 prostate cancer, and suggest that this marker can be used to monitor the clinical course of these patients.Keywords
This publication has 16 references indexed in Scilit:
- Hormone-Negative, Chromogranin a-Positive Endocrine TumorsNew England Journal of Medicine, 1989
- Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glandsThe Prostate, 1988
- Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regenerationThe Prostate, 1988
- Small cell carcinoma of the prostate part I a clinicopathologic study of 20 casesCancer, 1987
- Xenografted small cell undifferentiated cancer of prostate: Possible common origin with prostatic adenocarcinomaThe Prostate, 1987
- Secretion of Chromogranin A by Peptide-Producing Endocrine NeoplasmsNew England Journal of Medicine, 1986
- Endocrine cells in the prostate gland, urothelium and brenner tumorsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1982
- The endocrine component of prostatic carcinomas, mixed adenocarcinoma-carcinoid tumours and non-tumour prostate. Histochemical and ultrastructural identification of the endocrine cellsHistopathology, 1981
- Argentaffin and argyrophil cells in the prostateThe Journal of Pathology, 1974
- Argentaffin cells in prostatic carcinoma: Differentiation from lipofuscin and melanin in prostatic epitheliumThe Journal of Pathology, 1971